Description
Product Introduction
CAPIVEX 200mg Tablet contains Capivasertib and is used for selected HR-positive, HER2-negative advanced breast cancer with susceptible alterations. The product should be used only according to the applicable prescribing information and under the supervision of a qualified healthcare professional. Product presentation, approved indications and availability may vary between countries.
Uses of CAPIVEX 200mg
- Used for selected HR-positive, HER2-negative advanced breast cancer with susceptible alterations.
- Used according to the applicable approved indication and local prescribing information.
- May be supplied as part of a patient-specific or healthcare-professional-directed medicine requirement, subject to applicable regulations.
Benefits in Treatment
- inhibits AKT signalling in the PI3K/AKT pathway.
- Provides a treatment option for eligible patients when prescribed according to the approved indication.
- Therapy should be individualised based on the patient’s clinical condition and healthcare professional’s assessment.
Side Effects of CAPIVEX 200mg
Possible side effects may include diarrhea, rash, nausea, hyperglycemia and fatigue. The exact safety profile depends on the active ingredient, dose, formulation, duration of treatment, and patient-specific factors.
- Seek medical advice promptly if severe, persistent, or unusual symptoms occur.
- Inform the healthcare professional about all prescription medicines, over-the-counter medicines, supplements, and relevant medical conditions.
- Do not change the dose or stop treatment without consulting the prescribing healthcare professional.
Quick Tips
- Use CAPIVEX exactly as prescribed by the healthcare professional.
- Follow the product-specific administration, storage, and handling instructions on the label.
- Check the strength, dosage form, batch details, and expiry date before use or supply.
- Keep the medicine out of reach of children and store it according to the specific product label.
- For international supply, verify the destination-country regulatory, prescription, import, and documentation requirements before ordering.
To Order: order@srkpharma.com
Patient Assistance Program (PAP) or Patient Named Program – We also support Patient Assistance Programs (PAPs) and Patient Named Programs, helping eligible patients access required medicines through a patient-focused and streamlined process. We support patients and healthcare partners with product sourcing, documentation, order coordination, and delivery assistance, subject to applicable program requirements and country regulations. We support medicine supply through PAP and Patient Named Programs across countries including the USA, UK, Canada, Australia, India, Brazil, Nigeria, South Africa, UAE, Saudi Arabia, Germany, France, Italy, Spain, Singapore, Malaysia, and other international markets. Our goal is to make access to essential medicines simpler, reliable, and patient-focused, while supporting patients and healthcare partners throughout the supply process.




Reviews
There are no reviews yet.